Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 202

    1.

    Potentiation of vitamin K antagonists by high-dose intravenous methylprednisolone.

    Costedoat-Chalumeau N, Amoura Z, Aymard G, Sevin O, Wechsler B, Cacoub P, Du LT, Diquet B, Ankri A, Piette JC.

    Ann Intern Med. 2000 Apr 18;132(8):631-5.PMID: 10766681 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Potentiation of fluindione or warfarin by dexamethasone in multiple myeloma and AL amyloidosis.

    Sellam J, Costedoat-Chalumeau N, Amoura Z, Aymard G, Choquet S, Trad S, Vignes BL, Hulot JS, Berenbaum F, Lechat P, Cacoub P, Ankri A, Mariette X, Leblond V, Piette JC.

    Joint Bone Spine. 2007 Oct;74(5):446-52. Epub 2007 Jul 6.PMID: 17692552 [PubMed - indexed for MEDLINE]Related articles

    3.

    Dietary vitamin K variability affects International Normalized Ratio (INR) coagulation indices.

    Couris R, Tataronis G, McCloskey W, Oertel L, Dallal G, Dwyer J, Blumberg JB.

    Int J Vitam Nutr Res. 2006 Mar;76(2):65-74.PMID: 16941417 [PubMed - indexed for MEDLINE]Related articles

    4.

    Beraprost sodium-fluindione combination in healthy subjects: pharmacokinetic and pharmacodynamic aspects.

    Warot D, Berlin I, Aymard G, Ankri A, Fabry C, Besse B, Lechat P, Diquet B.

    Fundam Clin Pharmacol. 2000 May-Jun;14(3):231-6.PMID: 15602800 [PubMed - indexed for MEDLINE]Related articles

    5.

    Relationship between international normalized ratio values, vitamin K-dependent clotting factor levels and in vivo prothrombin activation during the early and steady phases of oral anticoagulant treatment.

    D'Angelo A, Della Valle P, Crippa L, Fattorini A, Pattarini E, Viganò D'Angelo S.

    Haematologica. 2002 Oct;87(10):1074-80.PMID: 12368163 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Low dose oral vitamin K to reverse acenocoumarol-induced coagulopathy: a randomized controlled trial.

    Ageno W, Crowther M, Steidl L, Ultori C, Mera V, Dentali F, Squizzato A, Marchesi C, Venco A.

    Thromb Haemost. 2002 Jul;88(1):48-51.PMID: 12152676 [PubMed - indexed for MEDLINE]Related articles

    8.

    Invasive procedures in the outpatient setting: managing the short-acting acenocoumarol and the long-acting phenprocoumon.

    van Geest-Daalderop JH, Hutten BA, Péquériaux NC, de Vries-Goldschmeding HJ, Räkers E, Levi M.

    Thromb Haemost. 2007 Oct;98(4):747-55.PMID: 17938797 [PubMed - indexed for MEDLINE]Related articles

    9.

    [Comparison of Quick/INR values of whole capillary blood (CoaguChek Plus) and venous citrate plasma in patients with and without oral anticoagulation]

    Burri S, Demarmels Biasiutti F, Lämmle B, Wuillemin WA.

    Schweiz Med Wochenschr. 1998 Oct 31;128(44):1723-9. German. PMID: 9846345 [PubMed - indexed for MEDLINE]Related articles

    10.

    Predicting daily maintenance dose of fluindione, an oral anticoagulant drug.

    Cazaux V, Gauthier B, Elias A, Lefebvre D, Tredez J, Nguyen F, Cambus JP, Boneu B, Boccalon H.

    Thromb Haemost. 1996 May;75(5):731-3.PMID: 8725714 [PubMed - indexed for MEDLINE]Related articles

    11.

    Impact of pre-treatment INR level on the effect of intravenous low dose vitamin K in patients with excessive anticoagulation.

    Lubetsky A, Shasha Y, Olchovsky D, Loebstein R, Halkin H, Ezra D.

    Thromb Haemost. 2003 Jul;90(1):71-6. Review.PMID: 12876628 [PubMed - indexed for MEDLINE]Related articles

    12.

    Optimal dose of prothrombin complex concentrate for acute reversal of oral anticoagulation.

    Yasaka M, Sakata T, Naritomi H, Minematsu K.

    Thromb Res. 2005;115(6):455-9.PMID: 15792675 [PubMed - indexed for MEDLINE]Related articles

    13.

    Transition from argatroban to oral anticoagulation with phenprocoumon or acenocoumarol: effect on coagulation factor testing.

    Walenga JM, Drenth AF, Mayuga M, Hoppensteadt DA, Prechel M, Harder S, Watanabe H, Osakabe M, Breddin HK.

    Clin Appl Thromb Hemost. 2008 Jul;14(3):325-31.PMID: 18586683 [PubMed - indexed for MEDLINE]Related articles

    14.

    Transition from argatroban to oral anticoagulation with phenprocoumon or acenocoumarol: effects on prothrombin time, activated partial thromboplastin time, and Ecarin Clotting Time.

    Harder S, Graff J, Klinkhardt U, von Hentig N, Walenga JM, Watanabe H, Osakabe M, Breddin HK.

    Thromb Haemost. 2004 Jun;91(6):1137-45.PMID: 15175800 [PubMed - indexed for MEDLINE]Related articles

    15.

    [Prospective study of oral anticoagulation control in 110 very elderly hospitalized patients and of risk factors for poor control]

    Vogel T, Coriol V, Kaltenbach G, Kiesmann M, Berthel M.

    Presse Med. 2008 Dec;37(12):1723-30. Epub 2008 Jul 17. French. PMID: 18644323 [PubMed - indexed for MEDLINE]Related articles

    16.

    Patients who take uneven doses of acenocoumarol exhibit significant fluctuating levels of anticoagulation.

    Marco F, Gutiérrez JI, Orkolaga K, Márquez JA, Ojínaga MJ, de Zárate IO, de Heredia JM.

    Blood Coagul Fibrinolysis. 2006 Sep;17(6):509-12.PMID: 16905959 [PubMed - indexed for MEDLINE]Related articles

    17.

    [Determination of regimen fluindione needed for anticoagulation in the elderly]

    Lechowski L, Teillet L, Harboun M, Tortrat D, Forette B.

    Rev Med Interne. 2002 Dec;23(12):1022-6. French. PMID: 12504240 [PubMed - indexed for MEDLINE]Related articles

    18.

    Modeling INR data to predict maintenance fluindione dosage.

    Comets E, Mentré F, Pousset F, Diquet B, Montalescot G, Ankri A, Mallet A, Lechat P.

    Ther Drug Monit. 1998 Dec;20(6):631-9.PMID: 9853979 [PubMed - indexed for MEDLINE]Related articles

    19.

    [Excess antivitamin K in elderly hospitalised patients aged over 70. A one-year prospective survey]

    Siguret V, Esquirol C, Debray M, Gouin I, Andreux JP, Pautas E.

    Presse Med. 2003 Jun 14;32(21):972-7. French. PMID: 12876525 [PubMed - indexed for MEDLINE]Related articles

    20.

    The influence on INRs and coagulation factors of the time span between blood sample collection and intake of phenprocoumon or acenocoumarol: consequences for the assessment of the dose.

    van Geest-Daalderop JH, Hutten BA, Péquériaux NC, Haas FJ, Levi M, Sturk A.

    Thromb Haemost. 2007 Oct;98(4):738-46.PMID: 17938796 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data